Decellularized Human Placental Extracellular Matrix Tissue for Rotator Cuff Repair Augmentation
ECMRCR
1 other identifier
interventional
120
1 country
1
Brief Summary
The rotator cuff is a set of muscles and tendons that help move the shoulder. Tears in the rotator cuff are common, particularly as people age. Consequently, rotator cuff repair surgeries are common, as well. Despite the frequency with which rotator cuff repairs are performed, there remains a high rate of postoperative failure to heal. In such situations, there is a lack of connective tissue establishment between the rotator cuff tendon and the bone. One strategy to attempt to improve healing of the rotator cuff tendon back to the bone is via the use of extracellular matrix allograft. This treatment is composed of tissue from other humans, which is stripped of its cells so that just the scaffolding around the cells remains. This decellularized scaffolding can be placed at the rotator cuff healing site in an attempt to augment healing. Both animal studies and human studies have shown promise with this approach. Of those patients enrolling in the study, 50% will be assigned at random to receive a standard rotator cuff repair AND allograft treatment, while 50% will be assigned at random to receive standard rotator cuff repair WITHOUT allograft treatment. All patients enrolled in the study will also obtain an MRI at one year following surgery in order to assess tendon healing. Of note, one-year postoperative MRIs are not standard following rotator cuff repair - only those enrolled in the study will receive this MRI. There will be no financial consequence of receiving this MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2025
CompletedFirst Posted
Study publicly available on registry
June 18, 2025
CompletedStudy Start
First participant enrolled
August 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
Study Completion
Last participant's last visit for all outcomes
July 1, 2027
April 16, 2026
April 1, 2026
11 months
June 11, 2025
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retear Rate
The primary outcome measure will be the postoperative retear rate, measured on one-year postoperative MRI
1 year
Secondary Outcomes (7)
Tendon Structural Continuity (MRI)
1 year
Tendon Thickness (MRI)
1 year
Constant-Murley score
1 year
American Shoulder and Elbow Surgeons (ASES) score
1 year
Visual Analogue Scale (VAS) Pain scores
1 year
- +2 more secondary outcomes
Study Arms (2)
Treatment Arm
EXPERIMENTALStandard Rotator Cuff Repair + Receives Allograft Treatment
Control Arm
OTHERStandard Rotator Cuff Repair + NO Allograft Treatment
Interventions
Rotator cuff repairs will be augmented with use of a decellularized human placental allograft patch
Standard rotator cuff repair with no augmentation
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Diagnosis of full thickness rotator cuff tear
You may not qualify if:
- Partial thickness tears
- Full thickness subscapularis tears
- Goutallier grades 3 and 4
- Prior rotator cuff surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- CTM Biomedicalcollaborator
Study Sites (1)
NewYorkPresbyterian Hospital @ Columbia
New York, New York, 10032-3702, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William Levine, MD
Columbia University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2025
First Posted
June 18, 2025
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
April 16, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share